Dormicum 7.5mg. 15mg Tablets
PDF Leaflet Revision Date: 02 March 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Short-term treatment of severe insomnia and anaesthetic premedication.
Dosage (summary)
Adults: 7.5 mg to 15 mg; Elderly: 7.5 mg.
Special Populations
- Elderly
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Avoid in pregnancy; may cause congenital malformations. Not recommended during lactation.
Key Drug Interactions
- CYP3A inhibitors
- CYP3A inducers
- Alcohol and CNS depressants
Contraindications
- Hypersensitivity to benzodiazepines
- Myasthenia gravis
- Severe hepatic impairment
- Children under 12 years
- Respiratory insufficiency
Common side effects
- Somnolence
- Dizziness
- Amnesia
- Fatigue
- Respiratory depression
Counselling Points
- Take just before bed
- Do not abruptly discontinue
- Avoid alcohol
- May impair ability to drive or operate machinery
Serious warnings
- Risk of dependence and withdrawal symptoms
- Tolerance may develop
- Paradoxical reactions
Important Disclaimer
The Dormicum 7.5mg. 15mg Tablets professional information leaflet below is the property of Roche Products and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
